NYMXF — Nymox Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Nymox Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.83	1.4	0.07	0.074	0.006
Net Total Accounts Receivable
Net Total Receivables	0.013	0.01	0.011	0.027	0.022
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.04	1.46	0.625	0.653	0.575
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.406	0.168	0.002	0.001	0.001
Total Assets	1.44	1.63	0.627	0.654	0.576
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.79	2.11	3.8	7.43	9.88
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	1.95	2.11	3.8	7.43	9.88
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.506	-0.482	-3.17	-6.78	-9.3
Total Liabilities & Shareholders' Equity	1.44	1.63	0.627	0.654	0.576
Total Common Shares Outstanding